We publish our translational research with animal models in neuroscience and neuropharmacology-related journals. For the most up-to-date list of publications, see Pubmed.
- Barker-Haliski M, Hawkins NA. Innovative drug discovery strategies in epilepsy: integrating next-generation syndrome-specific mouse models to address pharmacoresistance and epileptogenesis. Expert Opin Drug Discov. 2024 Sep;19(9):1099-1113. doi: 10.1080/17460441.2024.2384455. Epub 2024 Jul 29. PMID: 39075876; PMCID: PMC11390315.
- Smukowski SN, Danyko C, Somberg J, Kaufman EJ, Course MM, Postupna N, Barker-Haliski M, Keene CD, Valdmanis PN. mRNA and circRNA mislocalization to synapses are key features of Alzheimer’s disease. PLoS Genet. 2024 Jul 29;20(7):e1011359. doi: 10.1371/journal.pgen.1011359. PMID: 39074152; PMCID: PMC11309398.
- Zierath DK, Davidson S, Manoukian J, Knox KM, White HS, Meeker S, Ericsson A, Barker-Haliski M. Diet composition and sterilization modifies intestinal microbiome diversity and burden of Theiler’s virus infection-induced acute seizures. Epilepsia. 2024 Jun;65(6):1777-1790. doi: 10.1111/epi.17946. Epub 2024 Mar 16. PMID: 38491947.
- Del Pozo A, Knox KM, Lehmann LM, Davidson S, Rho SL, Jayadev S, Barker-Haliski M. Chronic evoked seizures in young pre-symptomatic APP/PS1 mice induce serotonin changes and accelerate onset of Alzheimer’s disease-related neuropathology. Prog Neurobiol. 2024 Apr;235:102591. doi: 10.1016/j.pneurobio.2024.102591. Epub 2024 Mar 13. PMID: 38484965; PMCID: PMC11015961.
- Lehmann LM, Barker-Haliski M. Loss of normal Alzheimer’s disease-associated Presenilin 2 function alters antiseizure medicine potency and tolerability in the 6-Hz focal seizure model. Front Neurol. 2023 Aug 1;14:1223472. doi: 10.3389/fneur.2023.1223472. PMID: 37592944; PMCID: PMC10427874.
- Zierath D, Mizuno S, Barker-Haliski M. Frontline Sodium Channel-Blocking Antiseizure Medicine Use Promotes Future Onset of Drug-Resistant Chronic Seizures. Int J Mol Sci. 2023 Mar 2;24(5):4848. doi: 10.3390/ijms24054848. PMID: 36902275; PMCID: PMC10003379.